Indoco receives UK-MHRA approval
This approval is the outcome of the inspection of Goa Plant I, which was conducted in December 2016
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Bayer wins ‘Best Employer in India 2017’ Award
Study methodology involved a nine-month evaluation by an external panel of independent jury
Allow co-prescription of brands and generics: IDMA to PM
The association suggests that the government should abolish tax on all medicines and subsidise the price of medicines as is done…
US court rules in favour of Zydus Cadila in patent case
The US Court of Appeals for the Federal Circuit has affirmed judgement holding that Zydus Cadila's proposed generic version of…
Natco Pharma launches generic blood cancer drug in India
The company has priced its generic medicine of POMALID 1 mg, 2 mg, and 4 mg capsules at an MRP Rs 5,000, Rs 10,000 and Rs 20,000…
Allow co-prescription of brands and generic: IDMA to PM
Says branded and generics markets can complement and supplement each other
US FDA makes eight observations at Lupin’s Aurangabad unit
The inspection was completed on April 26, 2017
Rajasthan Antibiotics to raise Rs 50 crore VC Funding
The funding would be pumped into company expansion through Greenfield and Brownfield
Torrent completes acquisition of Novartis brands
The two brands are widely prescribed by gynaecologists for the management of abnormal uterine bleeding, post menopausal symptoms…
VWR enters into definitive agreement with Avantor
The agreement will create a vertically integrated, global player in manufacturing and supply chain solutions for the life…
CPhI Worldwide Advisory Board inducts five new global experts
The board will help to steer the overall development of CPhI events and content
CPhI Worldwide, organised by UBM EMEA, has…
Hetero receives generic ‘Sofosbuvir+Velpatasvir’ approval from DCG(I)
The product will be marketed and distributed under the brand name ‘Velasof’ in India
Hester Biosciences net profit up by 29 per cent in Q4 FY17
The company has recommended final dividend of Rs 2.30 per share
Withdraw ‘TRIPS-plus’ proposals: MSF to Japan, S Korea
Response targets the 18th round of the RCEP trade talks, to be held in Manila this week
Wockhardt seeks shareholders’ nod to raise Rs 1,000 cr
The shareholders can approve the resolution through e-voting or physical postal ballot form
Strides Shasun maintains ‘Zero 483’ Status
Three facilities were inspected by US FDA and were cleared with Zero 483 Status in the last one month
Kiran Mazumdar-Shaw receives AWSM Award for Excellence 2017
The Sixth Annual AWSM Awards were hosted by a wing of The Feinstein Institute for Medical Research, US
Wockhardt releases financial report for Q4FY17
Posts net sales of Rs 864 crore and revenue of Rs 4,015 crore
The push towards pure generics: Impact on pharma marketing
Mala Raj, Senior Pharma Marketing and Medical Consultant at PMS Services contemplates the consequences of the generic push on some…
Veeva releases survey on digitalisation in Indian pharma
Reports reveals 66 per cent of respondents believe digital will become core to company strategy over the next three years